Search results (54)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas in the MRC Weatherall Institute of Molecular Medicine, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
Professor Ester Hammond Awarded Brain Research UK Funding to Tackle Paediatric High-Grade Glioma
10 March 2026
Ester Hammond, Professor of Molecular Cancer Biology in the Department of Oncology, has been awarded new funding from Brain Research UK to investigate much needed treatment options for paediatric high-grade glioma (pHGG), the most common cause of tumour-related death in children.
Oxford Researchers Join Global Cancer Grand Challenges Teams
4 March 2026
Cancer Grand Challenges, a global initiative co-founded by the National Cancer Institute in the US and Cancer Research UK, today announced a major $125m commitment to propel cancer research into uncharted territory. Five pioneering international teams – two of which include researchers from the University of Oxford - will each receive up to $25m over approximately five years to tackle some of the most ambitious and unanswered questions in cancer.
How Unstable Cancer Genomes Reshape the Tumour Landscape
19 February 2026
Chromosomal instability (CIN) is a hallmark of aggressive cancers, yet the mechanisms through which it shapes tumour behaviour and clinical outcomes remain poorly defined. With new funding from Guts UK and the University of Oxford Medical Sciences Division, Dr Bruno Beernaert, postdoctoral researcher in the Department of Oncology, is tackling this challenge by developing innovative approaches to uncover the role of CIN in tumour evolution and immune evasion.
New NIHR Oxford Senior Research Fellows named
9 January 2026
Eight mid-career researchers identified as having the potential to become future leaders in translational research have been appointed to the next cohort of NIHR Oxford Senior Research Fellows. Those named include Rubeta Matin, Oxford Research Lead for Dermatology Skin Cancer Clinical Trials, and Dr Sarah Gooding, Cancer Research UK Clinician Scientist based at the Weatherall Institute of Molecular Medicine.
Oxford researchers win first and second place in MRC's 2025 Festive Science Image Competition.
19 December 2025
2nd place was awarded to Nathalie Lövgren, DPhil Student, and Dr Iain Tullis, Senior Postdoctoral Researcher, in the Physics and Biology of FLASH Radiation Research Group at the University of Oxford. Nathalie and Iain's snowflake-inspired image was based on their work investigating a potential new radiation treatment for cancer.
The Translational Histopathology Laboratory achieves Good Clinical Laboratory Practice accreditation.
18 December 2025
The Translational Histopathology Laboratory (THL), part of the Oxford Experimental Cancer Medicine Centre (ECMC), has achieved Good Clinical Laboratory Practice (GCLP) accreditation, marking an important milestone in the delivery of high-quality, standardised tissue analysis for the cancer research community in Oxford.
Kendra Perez-Smith receives Outstanding Contribution to Sustainability Award
18 December 2025
Kendra Perez-Smith, Translational Support Unit (TSU) Manager in the Department of Oncology, has received an Outstanding Contribution to Sustainability Award in recognition of her innovation and leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.
New Study to Investigate How Immunometabolism Shapes Treatment Responses in Pancreatic Cancer
5 December 2025
Keaton Jones, Consultant Hepatobiliary and Pancreatic Surgeon at Oxford University Hospitals NHS Foundation Trust and Senior Clinical Researcher in the Department of Oncology at the University of Oxford, has received a Wellcome Trust Early Career Award to investigate the role of macrophage metabolism in determining therapeutic responses in pancreatic cancer.
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
17 November 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
Michael Bryan wins international award at Europe’s largest cancer conference
24 October 2025
Michael - who is a CRUK Oxford Centre DPhil in Cancer Science student, working in the Nuffield Department of Medicine's Centre of Immuno-oncology - has been awarded the Best Poster Prize in CNS Tumours at the 2025 European Society for Medical Oncology (ESMO) Congress.
Oxford Cancer Announces 2025 CRIS Cancer Clinical Career Fellows
13 October 2025
Oxford Cancer, together with the CRIS Cancer Foundation, is delighted to announce the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Dr Rebecca Ling and Dr Casmir Turnquist. Both Fellows will lead on two distinct projects focused on childhood cancer.
Oxford Clinical Researcher Awarded NIHR EME Funding to Study Impact of Insulin Levels on Breast Cancer Treatment Response
1 August 2025
Associate Professor Simon Lord, Director of the Early Phase Clinical Trials Unit within the Department of Oncology and Consultant Medical Oncologist at Oxford University Hospitals NHS Foundation Trust, has been awarded funding from the NIHR to launch a clinical study investigating the impact of insulin resistance on response to endocrine therapy in patients with oestrogen receptor (ER)-positive breast cancer.
Vice-Chancellor's Breakthrough Researcher Award for Dr Joshua Bull
20 May 2025
The University honoured remarkable talent and dedication to excellence on Thursday 15 May as the winners of the Vice-Chancellor's Awards 2025 were announced. Congratulations to Dr Joshua Bull from the Mathematical Institute, who received the Breakthrough Researcher Award.
Professor Andrew McMichael elected to the US National Academy of Sciences
6 May 2025
The National Academy of Sciences (NAS) in the US just announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.
Oxford success in the 2024 Lasker Essay Contest
16 July 2024
Subashan Vadibeler, a recent Oxford Rhodes scholar and MRes student, is one of five co-winners of the international 2024 Essay Contest sponsored by the Lasker Foundation.
Prof Anindita Roy awarded CRUK funding to study infant acute lymphoblastic leukaemia
30 May 2024
Congratulations to Professor Anindita Roy who successfully applied for a CRUK Data4CYP award!
Oxford Cancer: 5 minutes with Professor Dame Molly Stevens
23 May 2024
Professor Dame Molly Stevens is John Black Professor of Bionanoscience in the Department of Physiology, Anatomy and Genetics and the Institute of Biomedical Engineering. She recently moved her lab from Imperial College London to the University of Oxford and the Kavli Institute for nanoscience discovery, and she is joining the Oxford Cancer community.
Oxford Cancer researchers elected as Fellows of the Academy of Medical Sciences
22 May 2024
The Academy of Medical Sciences has elected four Oxford Cancer biomedical and health scientists to its fellowship in 2024.
Oxford Cancer Professor Yang Shi honoured by the Royal Society
16 May 2024
Ludwig Oxford Professor Yang Shi has been elected as a Fellow of the Royal Society for his contributions to epigenetics research.